Maximus (MMS) Earns Daily Media Sentiment Score of 0.15

Press coverage about Maximus (NYSE:MMS) has trended somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Maximus earned a daily sentiment score of 0.15 on Accern’s scale. Accern also assigned media stories about the health services provider an impact score of 45.8991211622529 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the media stories that may have impacted Accern Sentiment Analysis’s analysis:

How to Become a New Pot Stock Millionaire

Shares of MMS opened at $70.73 on Thursday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.57 and a quick ratio of 2.57. The firm has a market capitalization of $4,527.15, a price-to-earnings ratio of 23.34, a price-to-earnings-growth ratio of 2.40 and a beta of 1.12. Maximus has a fifty-two week low of $58.43 and a fifty-two week high of $72.71.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 8th. The health services provider reported $0.78 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.77 by $0.01. The company had revenue of $623.10 million during the quarter, compared to the consensus estimate of $624.36 million. Maximus had a return on equity of 22.93% and a net margin of 8.99%. Maximus’s revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.71 EPS. analysts forecast that Maximus will post 3.31 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 31st. Shareholders of record on Tuesday, May 15th will be issued a $0.045 dividend. The ex-dividend date of this dividend is Monday, May 14th. This represents a $0.18 annualized dividend and a yield of 0.25%. Maximus’s dividend payout ratio (DPR) is presently 5.94%.

Several brokerages recently issued reports on MMS. Zacks Investment Research downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, April 12th. Canaccord Genuity cut their price objective on Maximus from $71.00 to $65.00 and set a “hold” rating for the company in a research report on Friday, February 9th. Finally, Maxim Group reiterated a “hold” rating and issued a $69.00 price target (up from $66.00) on shares of Maximus in a report on Thursday, February 8th. One analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $66.60.

In other news, CEO Richard A. Montoni sold 30,000 shares of the company’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $67.89, for a total transaction of $2,036,700.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Russell A. Beliveau sold 1,000 shares of the company’s stock in a transaction on Monday, April 2nd. The stock was sold at an average price of $66.55, for a total value of $66,550.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 44,600 shares of company stock valued at $3,009,650. Insiders own 2.48% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Maximus (MMS) Earns Daily Media Sentiment Score of 0.15” was originally posted by Week Herald and is owned by of Week Herald. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with's FREE daily email newsletter.

Leave a Reply